Targeting the Inflammatory Pathway as a Therapeutic Tool for Major Depression

Publisher： Karger

E-ISSN： 1423-0216|21|2-3|131-139

ISSN： 1021-7401

Source： Neuroimmunomodulation, Vol.21, Iss.2-3, 2014-02, pp. : 131-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunology of Major Depression

By  

Neuroimmunomodulation, Vol. 21, Iss. 2-3, 2014-02 ,pp. : 123-130

Karger

Access to resources Recommend Favorite

A Follow-Up Study of 50 Chronic Hepatitis C Patients: Adiponectin as a Resilience Biomarker for Major Depression

By  

Neuroimmunomodulation, Vol. 23, Iss. 2, 2016-04 ,pp. : 88-97

Karger

Access to resources Recommend Favorite

Neuroimmunoendocrine Interactions in Patients with Recurrent Major Depression, Increased Early Life Stress and Long-Standing Posttraumatic Stress Disorder Symptoms

By  

Neuroimmunomodulation, Vol. 19, Iss. 1, 2011-11 ,pp. : 33-42

Karger

Access to resources Recommend Favorite

Serotonin, 5-HT1A Serotonin Receptors and Proliferation of Lymphocytes in Major Depression Patients

By  

Neuroimmunomodulation, Vol. 14, Iss. 1, 2007-08 ,pp. : 8-15

Karger

Access to resources Recommend Favorite

Allelic Isoforms and Decrease in Serotonin Transporter mRNA in Lymphocytes of Patients with Major Depression

By  

Neuroimmunomodulation, Vol. 12, Iss. 5, 2005-09 ,pp. : 299-306

Karger

Access to resources Recommend Favorite